Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
CJC Pediatr Congenit Heart Dis ; 2(2): 63-73, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-37970523

RESUMO

Background: Congenital heart disease (CHD) survival rate has improved dramatically due to advances in diagnostic and therapeutic techniques. However, concerning the unrepaired CHD population of moderate and severe complexity, the data regarding risk predictors and surgical outcomes are scarce. Our aim was to describe the surgical results and predictors of in-hospital outcomes in adult patients with moderate-to-severe complexity CHD that were not repaired in childhood. Methods: We conducted a retrospective cohort study that included 49 adult patients with moderate-to-complex CHD who were treated in a single medical centre. Clinical and echocardiographic variables were obtained on admission, after surgical procedures and during follow-up. Results: Most of the patients were female (66%). Left ventricular ejection fraction and right ventricular outflow tract fractional shortening were within the normal range. The median pulmonary artery systolic pressure was 37 (27-55) mm Hg. The median time was 118 (80-181) minutes for extracorporeal circulation and 76 (49-121) minutes for aortic cross-clamping. The most frequent complication was postoperative complete atrioventricular block (12.2%). In-hospital survival rate was 87.7%. The development of low cardiac output syndrome with predominant right ventricle failure in the postoperative period was the most important predictor of in-hospital death (P = 0.03). Conclusions: Deciding to treat adults with CHD is challenging in moderate and severe unrepaired cases. Adequate clinical, functional, and imaging evaluation is essential to determine each patient's suitability for surgical management and to achieve the best clinical outcome for this population.


Contexte: Grâce aux avancées réalisées en matière de techniques diagnostiques et thérapeutiques, la survie des patients atteints d'une cardiopathie congénitale s'est considérablement améliorée. Cependant, en ce qui concerne les personnes atteintes d'une cardiopathie congénitale non corrigée présentant une complexité modérée ou extrême, les données portant sur les facteurs de risque prédictifs ainsi que sur les résultats chirurgicaux sont rares. Notre objectif était de décrire les résultats chirurgicaux ainsi que les facteurs prédictifs des résultats obtenus en milieu hospitalier chez les patients adultes atteints d'une cardiopathie congénitale présentant une complexité modérée ou extrême qui n'a pas été corrigée pendant l'enfance. Méthodologie: Nous avons mené une étude de cohorte rétrospective comprenant 49 patients adultes atteints d'une cardiopathie congénitale modérée ou complexe qui ont reçu leurs traitements dans un seul centre médical. Les variables cliniques et échocardiographiques ont été obtenues au moment de l'admission, après les interventions chirurgicales et pendant la période de suivi. Résultats: Les patients étaient en majorité des femmes (66 %). La fraction d'éjection du ventricule gauche ainsi que la fraction de raccourcissement de la voie d'éjection ventriculaire droite sont demeurées dans les limites de la normale. La pression systolique médiane de l'artère pulmonaire a été de 37 mmHg (27-55 mmHg). Le temps médian écoulé pour la circulation extracorporelle a été de 118 minutes (80-181 minutes) et pour le clampage de la crosse aortique, de 76 minutes (49-121 minutes). Le bloc auriculo-ventriculaire postopératoire complet a été la complication la plus fréquente (12,2 %). Le taux de survie en milieu hospitalier a été de 87,7 %. Le développement du syndrome du faible débit cardiaque accompagné d'une insuffisance prédominante du ventricule droit durant la période postopératoire a constitué le principal facteur prédictif de décès à l'hôpital (p = 0,03). Conclusion: Il est difficile de traiter les adultes qui présentent une cardiopathie congénitale modérée ou sévère non corrigée. Il est essentiel que les évaluations cliniques, fonctionnelles et par imagerie soient réalisées de façon adéquate pour déterminer si une prise en charge chirurgicale convient aux patients et pour garantir les meilleurs résultats cliniques chez ces derniers.

2.
PeerJ ; 11: e15272, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37101788

RESUMO

Bacteriophages are the most abundant biological entity on the planet, having pivotal roles in bacterial ecology, animal and plant health, and in the biogeochemical cycles. Although, in principle, phages are simple entities that replicate at the expense of their bacterial hosts, due the importance of bacteria in all aspects of nature, they have the potential to influence and modify diverse processes, either in subtle or profound ways. Traditionally, the main application of bacteriophages is phage therapy, which is their utilization to combat and help to clear bacterial infections, from enteric diseases, to skin infections, chronic infections, sepsis, etc. Nevertheless, phages can also be potentially used for several other tasks, including food preservation, disinfection of surfaces, treatment of several dysbioses, and modulation of microbiomes. Phages may also be used as tools for the treatment of non-bacterial infections and pest control in agriculture; moreover, they can be used to decrease bacterial virulence and antibiotic resistance and even to combat global warming. In this review manuscript we discuss these possible applications and promote their implementation.


Assuntos
Infecções Bacterianas , Bacteriófagos , Terapia por Fagos , Animais , Bactérias , Infecções Bacterianas/terapia
3.
Front Cell Infect Microbiol ; 13: 1280265, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38298921

RESUMO

Background: Bacteriophage therapy is becoming part of mainstream Western medicine since antibiotics of clinical use tend to fail. It involves applying lytic bacteriophages that self-replicate and induce cell lysis, thus killing their hosts. Nevertheless, bacterial killing promotes the selection of resistant clones which sometimes may exhibit a decrease in bacterial virulence or antibiotic resistance. Methods: In this work, we studied the Pseudomonas aeruginosa lytic phage φDCL-PA6 and its variant φDCL-PA6α. Additionally, we characterized and evaluated the production of virulence factors and the virulence in a Galleria mellonella model of resistant mutants against each phage for PA14 and two clinical strains. Results: Phage φDCL-PA6α differs from the original by only two amino acids: one in the baseplate wedge subunit and another in the tail fiber protein. According to genomic data and cross-resistance experiments, these changes may promote the change of the phage receptor from the O-antigen to the core lipopolysaccharide. Interestingly, the host range of the two phages differs as determined against the Pseudomonas aeruginosa reference strains PA14 and PAO1 and against nine multidrug-resistant isolates from ventilator associated pneumonia. Conclusions: We show as well that phage resistance impacts virulence factor production. Specifically, phage resistance led to decreased biofilm formation, swarming, and type III secretion; therefore, the virulence towards Galleria mellonella was dramatically attenuated. Furthermore, antibiotic resistance decreased for one clinical strain. Our study highlights important potential advantages of phage therapy's evolutionary impact that may be exploited to generate robust therapy schemes.


Assuntos
Bacteriófagos , Mariposas , Terapia por Fagos , Fagos de Pseudomonas , Animais , Virulência , Pseudomonas aeruginosa , Fagos de Pseudomonas/genética , Fatores de Virulência/genética , Resistência Microbiana a Medicamentos , Antibacterianos/farmacologia
4.
J Alzheimers Dis ; 89(3): 931-941, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35964177

RESUMO

BACKGROUND: Dementia is a priority public health issue due to its high prevalence worldwide and its economic, social, and health impact. However, there are few reports in Mexico based on formal tests and with a clinical approach based on the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5). OBJECTIVE: This study estimates the prevalence of the main types of dementia among elderly people living in the community in Mexico City. METHODS: A population-based, two-step study was conducted, including 6,204 elderly individuals aged 60 or above with in-home assessment. All participants were screened for cognitive impairment; those who presented some cognitive problem underwent a standardized neurological examination. Each diagnosis was based on the criteria for dementia in the DSM-5, and the final consensus diagnosis of dementia was determined by an expert panel. RESULTS: The global estimated prevalence of dementia in the Mexican population was 7.8% met the criteria for Alzheimer's disease, 4.3% for vascular dementia, and 2.1% for mixed dementia. The prevalence of dementia was higher in women than in men (15.3% versus 12.5%, respectively). CONCLUSION: These results provide evidence to propose strategies for Latin American countries where dementia represents a challenge due to the heterogeneity of the populations and socioeconomic disparities, requiring early diagnosis and at the first levels of care.


Assuntos
Doença de Alzheimer , Demência , Idoso , Envelhecimento , Doença de Alzheimer/diagnóstico , Demência/diagnóstico , Demência/epidemiologia , Demência/psicologia , Feminino , Humanos , Masculino , México/epidemiologia , Prevalência
5.
PLoS One ; 16(11): e0258414, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34788287

RESUMO

BACKGROUND/AIM: Medication prescription is a fundamental component in the care of the elderly. Several characteristics of aging and geriatric medicine affect prescriptions for these people and make the selection of drug therapy a difficult and complex process. The objective of this study is to develop a geriatric portal for asynchronous online counseling (AGAlink) for use by physicians specializing in family medicine to reduce medication problems among older adult patients in the first level of care. METHOD: A qualitative study was carried out in the first level of care at the Mexican Institute of Social Security (IMSS), 31 family doctors were interviewed to identify attitudes, preferences about the use of the AGAlink geriatric portal, as well as their recommendations for the implementation of this tool in their daily practice. For the analysis of the data obtained, a qualitative thematic content analysis was used. RESULTS: 90% of the physicians used the geriatric portal outside office hours without the need for the patient to be present. The perception of the physician towards the use of the AGAlink geriatric portal was favorable, provided relevant information and had several positive effects on the process of care for medical prescription. The barriers identified to accept the change in medication were not having the proposed therapeutic option, lack of any laboratory analysis, continuing to consider their experience for the prescription of the medication. CONCLUSIONS: The AGAlink geriatric portal was a tool that was well received by physicians who expressed a positive attitude, considered an investment of a short time that allowed them to update and learn about strategies to reduce the prescription problems presented among the elderly population. However, the main barrier was the use of technology, especially in the doctors with more seniority in the service.


Assuntos
Aconselhamento , Geriatria , Prescrição Inadequada , Internet , Atenção Primária à Saúde , Adulto , Idoso , Feminino , Diretrizes para o Planejamento em Saúde , Humanos , Masculino , Inquéritos e Questionários
6.
Rev Med Inst Mex Seguro Soc ; 54 Suppl 2: S176-85, 2016.
Artigo em Espanhol | MEDLINE | ID: mdl-27561022

RESUMO

BACKGROUND: Frailty in elderly results from impaired physiological reserve in multiple systems. Establishing if frail elderly inpatients develop more functional impairment at discharge, will allow the development of strategies for preventing or limiting the deterioration in this vulnerable group. METHODS: Prospective cohort in 133 elderly inpatients. At admission, frailty, functional status, comorbidity and comprehensive geriatric evaluation were determined. The main outcome was functional state at hospital discharge. RESULTS: 64 patients presented frailty (48.1%) and 69 did not present that state (51.9%), with a mean age of 73 and 68 years, respectively. Mean decrement in functional state at discharge was -8.06 % (IC 95 % -10.38 to -5.74), from 97.97 % to 89.91 % (p < 0.001) in patients who did not present frailty, and -21.18 % (IC 95 % -24.97 to -17.38), from 87.52 % to 66.34 % (p < 0.001) in frail patients. The difference between groups at discharge was -14.37 % (IC 95 % -16.80 to -11.94, p < 0.001) to the detriment of the frail. Frailty was associated with functional impairment in the univariated and multivariated analysis, beta -13.11 % (IC 95 % -17.45 to -8.78, p < 0.001) and beta -17.27 (IC 95 % -23.27 to -11.28, p < 0.001), respectively. In the final model, frailty (beta -14.73, IC 95 % -19.39 to -10.07, p < 0.001) and cognitive impairment (beta -8.19, IC 95 % -15.28 to -1.10, p = 0.024) predict functional decrement. CONCLUSION: Frailty independently predicts functional impairment at hospital discharge.


Introducción: la fragilidad en ancianos es consecuencia de una menor reserva en múltiples sistemas fisiológicos. Determinar si pacientes frágiles al egreso hospitalario presentan mayor deterioro funcional permitirá diseñar estrategias que prevengan o limiten el deterioro en este grupo vulnerable. Métodos: cohorte prospectiva de 133 adultos hospitalizados, mayores de 60 años. Al ingreso se determinó fragilidad, estado funcional, comorbilidad y variables de la evaluación geriátrica. El desenlace de interés fue el estado funcional al egreso hospitalario. Resultados: hubo 64 participantes con fragilidad (48.1 %) y 69 sin fragilidad (51.9 %), cuya edad media fue de 73 y 68 años, respectivamente. El descenso promedio del estado funcional al egreso fue −8.06 % (intervalo de confianza [IC] al 95 % −10.38 a −5.74), de 97.97 a 89.91 % (p < 0.001) en no frágiles y −21.18 % (IC 95 % −24.97 a −17.38), de 87.52 a 66.34 % (p < 0.001) en frágiles. La diferencia entre grupos al egreso fue de −14.37 % (IC 95 % −16.80 a −11.94, p < 0.001) en detrimento de los frágiles. La fragilidad se asoció con deterioro funcional en el análisis simple y múltiple, beta −13.11 % (IC 95 % −17.45 a −8.78, p < 0.001) y beta −17.27 (IC 95 % −23.27 a −11.28, p < 0.001), respectivamente. En el modelo final, la fragilidad (beta −14.73, IC 95 % −19.39 a −10.07, p < 0.001) y el deterioro cognitivo (beta −8.19, IC 95 % −15.28 a −1.10, p = 0.024) predicen descenso funcional. Conclusión: la fragilidad predice independientemente deterioro funcional al egreso hospitalario.


Assuntos
Idoso Fragilizado , Avaliação Geriátrica , Hospitalização , Idoso , Idoso de 80 Anos ou mais , Feminino , Indicadores Básicos de Saúde , Humanos , Modelos Lineares , Masculino , Estudos Prospectivos
7.
Indian J Crit Care Med ; 20(12): 695-700, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28149026

RESUMO

CONTEXT: The performance of a prognostic score must be evaluated prior to being used. The aim of the present study was to evaluate the predictive ability of hospital mortality of Simplified Acute Physiology Score 3 (SAPS 3) score in elderly patients admitted to Intensive Care Units (ICUs). AIMS: The aim of the present study was to evaluate the SAPS 3 score predictive ability of hospital mortality in elderly patients admitted to ICU. SETTINGS AND DESIGN: This study was conducted as a prospective cohort, in two mixed ICUs. PATIENTS AND METHODS: Two hundred and eleven elderly patients were included. INTERVENTIONS: None. We compared the predictive accuracy of SAPS 3 measured at the first hour at ICU and Acute Physiology and Chronic Health Evaluation II (APACHE II) measured with the worst values in the first 24 h at ICU. The patients were followed until hospital discharge. STATISTICAL ANALYSIS USED: Evaluation of discrimination through area under curve receiver operating characteristic (aROC) and calibration by Hosmer-Lemeshow (HL) test. RESULTS: The median age was 68 years. The hospital mortality rate was 35.54%. The mean value of SAPS 3 was 62.54 ± 12.51 and APACHE II was 17.46 ± 6.77. The mortality predicted by APACHE II was 24.98 ± 19.96 and for standard SAPS 3 equation 41.18 ± 22.34. The discrimination for SAPS 3 model was aROC = 0.68 (0.62-0.75) and to APACHE II aROC = 0.70 (0.63-0.78). Calibration: APACHE II with HL 10.127 P = 0.26, and standard SAPS 3 equation HL 7.204 P = 0.51. CONCLUSIONS: In this study, the prognostic model of SAPS 3 was not found to be accurate in predicting mortality in geriatric patients requiring ICU admission.

8.
Basic Clin Pharmacol Toxicol ; 118(4): 298-305, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26432499

RESUMO

Adverse drug reactions impact on patient health, effectiveness of pharmacological therapy and increased health care costs. This investigation intended to detect the most critical drug-drug interactions in hospitalized elderly patients, weighting clinical risk. We conducted a cross-sectional study between January and April 2014; all patients 70 years or older, hospitalized for >24 hr and prescribed at least one medication were included in the study. Drug-drug interactions were estimated by combining Stockley's, Hansten and Tatro drug interactions. Drug-drug interactions were weighted using a risk-analysis method based on failure modes, effects and criticality analysis. We calculated a criticality index for each drug involved in the drug-drug interactions based on the severity of the interaction mechanism, the frequency the drug was involved in drug-drug interactions and the risk of drug-drug interactions in patients with impaired renal function. The average number of drugs consumed in the hospital was 6 ± 2.69, involving 160 active ingredients. The most frequent were as follows: Furosemide, followed by Enalapril. Of drug-drug interactions, 2% were classified as contraindicated, 14% advised against and 83% advised caution during the hospital stay. Thirty-four drug-drug interactions were assessed, of which 23 were pharmacodynamic drug-drug interactions and 12 were pharmacokinetic drug-drug interactions (1 was both). The clinical risk calculated for each drug-drug interaction included heparins + non-steroidal anti-inflammatory drugs (NSAIDs) or Digoxin + Calcium Gluconate, cases which are pharmacodynamic drug-drug interactions with agonist effect and clinical risk of bleeding, one of the most common clinical risks in the hospital. An index of clinical risk for drug-drug interactions can be calculated based on severity by the interaction mechanism, the frequency that the drug is involved in drug-drug interactions and the risk of drug-drug interactions in an elderly patient with impaired renal function.


Assuntos
Interações Medicamentosas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/etiologia , Hospitalização , Idoso , Idoso de 80 Anos ou mais , Estudos Transversais , Citocromo P-450 CYP2C19/metabolismo , Inibidores do Citocromo P-450 CYP2C19/efeitos adversos , Citocromo P-450 CYP3A/metabolismo , Inibidores do Citocromo P-450 CYP3A/efeitos adversos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/enzimologia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/epidemiologia , Hospitais com 300 a 499 Leitos/estatística & dados numéricos , Hospitalização/estatística & dados numéricos , Humanos , México , Modelos Teóricos
9.
Gac Med Mex ; 145(5): 401-6, 2009.
Artigo em Espanhol | MEDLINE | ID: mdl-20073445

RESUMO

OBJECTIVE: To determine the association between cognitive performance and long-term survival in an elderly Mexican population sample. METHODS: In this retrospective, retrolective and observational study elderly subjects were assessed in the Geriatrics Clinic of the Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" between January 1994 and August 1999 using a comprehensive geriatric assessment. All 2544 subjects for whom vitality status was known up to September 2002 were included in the analysis. Socio-demographic and health-related information was gathered during the clinical interview, and their emotional and functional status was determined using the Katz, Lawton and GDS scales. Cognition was measured using the Mini-Mental State Examination (MMSE), grouping the subjects according to their performance into four groups: normal-high performance, normal-low performance, mild-to-moderate impairment and moderate-to-severe impairment. Vitality status was determined by searching the hospital's clinical records or by telephonic contact with the patient or primary caregiver when needed. RESULTS: Long-term mortality rates increased in a linear fashion as MMSE scores decreased (p < 0.001), even for MMSE scores over 24. This association persisted even after adjustment for comorbidity, depression, functional status and socio-demographic factors. CONCLUSION: Patients showed a progressive decline in long-term survival according to their cognitive performances. MMSE scores between 24 and 27 were also associated with an increased mortality and should not be considered as normal, even if they are not sensitive enough to detect impairment.


Assuntos
Cognição , Idoso , Feminino , Hospitalização , Humanos , Masculino , Estudos Retrospectivos , Taxa de Sobrevida , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...